<p>This is a summary of the European public assessment report (EPAR) for Afstyla. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Afstyla.</p><p>For practical information about using Afstyla, patients should read the package leaflet or contact their doctor or pharmacist.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).</p> <p>Afstyla can be used for all age groups.</p></div>
Therapeutic Area (MeSH)
ATC Code
B02BD02
ATC Item
N/A
Pharmacotherapeutic Group
Antihemorrhagics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| lonoctocog alfa | N/A | lonoctocog alfa |
EMA Name
Afstyla
Medicine Name
Afstyla
Aliases
N/ANo risk management plan link.
